Akums Drugs & Pharmaceuticals Ltd.
Industry:
Pharmaceuticals & Drugs
Issue Details
Open Date
30 Jul 2024Close Date
01 Aug 2024Size (in Crs.)
1858.3
Size (Shares)
-Listing On
BSE, NSE
Issue Terms
Price Range
-33Lot Size
22
Type
Book building
Face Value
2
Market Lot
1
Objective of the Issue
a. Repayment/ prepayment of indebtedness of our Company;b. Repayment/ prepayment of indebtedness of our Subsidiaries namely, Maxcure Nutravedics Limited and Pure and Cure Healthcare Private Limited;c. Funding incremental working capital requirements of our Company;d. Pursuing inorganic growth initiatives through acquisitions; ande. General corporate purposes.
Description
Established in 2004, we are a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, we own the intellectual property for the manufacturing processes of several of our formulations, and our core business is focused on providing end-to-end product development and manufacturing solutions to our clients. Some of our other services include formulation research and... Show More
Address
304 Mohan Place, L S C , Saraswati Vihar ,
Delhi
110034
State
Delhi
Phone No.
011- 69041000
cs@akums.net
Website
www.akums.in
Promoter Holding
Promoters:
Akums Master Trust, Sandeep Jain, Sanjeev Jain
Total Share Capital
121528880
Offered to Public
27368151
% Promoter's Holding (Pre-Issue)
82.48
% Promoter's Holding (Post-Issue)
75.26
Shares on offer
Total Share Offer
121528880
Of above offred to public
27368151
Post Issue shares
NA
Post Issue Promoters
75.26
Lead Managers to the Issue:
Ambit Pvt Ltd., Axis Capital Ltd., Citigroup Global Markets India Pvt Ltd., ICICI Securities Ltd
Registrar Details
Registrar Name:
Link Intime India Pvt Ltd.
Address
C 101, 247 Park , LBS Marg , Vikhroli (West) , Mumbai
400083
Phone No.
+91 810 811 8484
helpdesk@linkintime.co.in
Website
www.linkintime.co.in
Fax
91-022-49186060